GlaxoSmithKline Pharma Q2 net profit up 32 percent at Rs 130 cr

New Delhi: Drug firm GlaxoSmithKline Pharmaceuticals reported a 31.83 percent rise in standalone net profit to Rs 130.32 crore for the second quarter ended September 30, 2017.

The company had posted a net profit of Rs 98.85 crore for the corresponding period of the previous fiscal, GlaxoSmithKline Pharmaceuticals said in a filing to BSE.

Standalone total income of the company also rose to Rs 845.87 crore for the quarter under consideration as against Rs 817.20 crore in the same period a year ago.